BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 17420980)

  • 1. Renal cell carcinoma clinically involving adjacent organs: experience with aggressive surgical management.
    Margulis V; Sánchez-Ortiz RF; Tamboli P; Cohen DD; Swanson DA; Wood CG
    Cancer; 2007 May; 109(10):2025-30. PubMed ID: 17420980
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Redefining pT3 renal cell carcinoma in the modern era: a proposal for a revision of the current TNM primary tumor classification system.
    Margulis V; Tamboli P; Matin SF; Meisner M; Swanson DA; Wood CG
    Cancer; 2007 Jun; 109(12):2439-44. PubMed ID: 17487856
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renal cell carcinoma with renal vein and inferior vena caval involvement: clinicopathological features, surgical techniques and outcomes.
    Parekh DJ; Cookson MS; Chapman W; Harrell F; Wells N; Chang SS; Smith JA
    J Urol; 2005 Jun; 173(6):1897-902. PubMed ID: 15879771
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oncological efficacy and safety of nephron-sparing surgery for selected patients with locally advanced renal cell carcinoma.
    Margulis V; Tamboli P; Jacobsohn KM; Swanson DA; Wood CG
    BJU Int; 2007 Dec; 100(6):1235-9. PubMed ID: 17979923
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Location of extrarenal tumor extension does not impact survival of patients with pT3a renal cell carcinoma.
    Margulis V; Tamboli P; Matin SF; Meisner M; Swanson DA; Wood CG
    J Urol; 2007 Nov; 178(5):1878-82. PubMed ID: 17868733
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic factors influencing long-term survival of patients undergoing nephron-sparing surgery for nonmetastatic renal-cell carcinoma (RCC) with imperative indications.
    Haferkamp A; Kurosch M; Pritsch M; Hatiboglu G; Macher-Goeppinger S; Pfitzenmaier J; Pahernik S; Wagener N; Hohenfellner M
    Ann Surg Oncol; 2010 Feb; 17(2):544-51. PubMed ID: 19953334
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Transabdominal radical nephrectomy for renal cell carcinoma: an experience on 155 patients].
    Chen XF; Zhou FJ; Han H; Qin ZK; Liu ZW; Yu SL; Li YH; Wang H; Hou GL
    Ai Zheng; 2007 May; 26(5):528-32. PubMed ID: 17672946
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictors of oncological outcome after resection of locally recurrent renal cell carcinoma.
    Margulis V; McDonald M; Tamboli P; Swanson DA; Wood CG
    J Urol; 2009 May; 181(5):2044-51. PubMed ID: 19286220
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Scoring algorithm to predict survival after nephrectomy and immunotherapy in patients with metastatic renal cell carcinoma: a stratification tool for prospective clinical trials.
    Leibovich BC; Han KR; Bui MH; Pantuck AJ; Dorey FJ; Figlin RA; Belldegrun A
    Cancer; 2003 Dec; 98(12):2566-75. PubMed ID: 14669275
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic factors of renal cell carcinoma with extension into inferior vena cava.
    Tanaka M; Fujimoto K; Okajima E; Tanaka N; Yoshida K; Hirao Y
    Int J Urol; 2008 May; 15(5):394-8. PubMed ID: 18452454
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic value of renal vein and inferior vena cava involvement in renal cell carcinoma.
    Wagner B; Patard JJ; Méjean A; Bensalah K; Verhoest G; Zigeuner R; Ficarra V; Tostain J; Mulders P; Chautard D; Descotes JL; de la Taille A; Salomon L; Prayer-Galetti T; Cindolo L; Valéri A; Meyer N; Jacqmin D; Lang H
    Eur Urol; 2009 Feb; 55(2):452-9. PubMed ID: 18692951
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic relevance of capsular involvement and collecting system invasion in stage I and II renal cell carcinoma.
    Klatte T; Chung J; Leppert JT; Lam JS; Pantuck AJ; Figlin RA; Belldegrun AS
    BJU Int; 2007 Apr; 99(4):821-4. PubMed ID: 17244281
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Local recurrence of renal cell carcinoma after nephrectomy].
    Pereverzev AS; Shchukin DV; Iliukhin IuA
    Urologiia; 2003; (6):14-8. PubMed ID: 14708237
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nephrectomy improves survival in patients with invasion of adjacent viscera and absence of nodal metastases (stage T4N0 renal cell carcinoma).
    Capitanio U; Perrotte P; Zini L; Jeldres C; Shariat SF; Isbarn H; Arjane P; Peloquin F; Pharand D; Montorsi F; Karakiewicz PI
    BJU Int; 2009 Sep; 104(6):795-9. PubMed ID: 19389018
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renal cell carcinoma with nodal metastases in the absence of distant metastatic disease (clinical stage TxN1-2M0): the impact of aggressive surgical resection on patient outcome.
    Canfield SE; Kamat AM; Sánchez-Ortiz RF; Detry M; Swanson DA; Wood CG
    J Urol; 2006 Mar; 175(3 Pt 1):864-9. PubMed ID: 16469567
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical outcome of surgical management for patients with renal cell carcinoma involving the inferior vena cava.
    Terakawa T; Miyake H; Takenaka A; Hara I; Fujisawa M
    Int J Urol; 2007 Sep; 14(9):781-4. PubMed ID: 17760741
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extent of lymph node dissection at nephrectomy affects cancer-specific survival and metastatic progression in specific sub-categories of patients with renal cell carcinoma (RCC).
    Capitanio U; Suardi N; Matloob R; Roscigno M; Abdollah F; Di Trapani E; Moschini M; Gallina A; Salonia A; Briganti A; Montorsi F; Bertini R
    BJU Int; 2014 Aug; 114(2):210-5. PubMed ID: 24854206
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of clinicopathologic predictors of oncologic outcome provides insight into the natural history of surgically managed papillary renal cell carcinoma.
    Margulis V; Tamboli P; Matin SF; Swanson DA; Wood CG
    Cancer; 2008 Apr; 112(7):1480-8. PubMed ID: 18240184
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surgical resection provides excellent outcomes for patients with cystic clear cell renal cell carcinoma.
    Webster WS; Thompson RH; Cheville JC; Lohse CM; Blute ML; Leibovich BC
    Urology; 2007 Nov; 70(5):900-4; discussion 904. PubMed ID: 18068445
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Postoperative surveillance protocol for patients with localized and locally advanced renal cell carcinoma based on a validated prognostic nomogram and risk group stratification system.
    Lam JS; Shvarts O; Leppert JT; Pantuck AJ; Figlin RA; Belldegrun AS
    J Urol; 2005 Aug; 174(2):466-72; discussion 472; quiz 801. PubMed ID: 16006866
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.